953039-79-7 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 2-chloroquinazolin-4-yl carbamate is used as a building block for the synthesis of therapeutic agents due to its characteristic chemical structure and biological activities. It contributes to the development of a range of pharmaceutical products, including anticancer drugs, antibiotics, and anti-inflammatory drugs.
However, it is important to note that the explicit uses or characteristics of the specific methyl 2-chloroquinazolin-4-yl carbamate compound may not be widely documented in the public domain due to its technical nature. Further scientific research and detailed investigation may be required to fully understand its applications and properties in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 953039-79-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,3,0,3 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 953039-79:
(8*9)+(7*5)+(6*3)+(5*0)+(4*3)+(3*9)+(2*7)+(1*9)=187
187 % 10 = 7
So 953039-79-7 is a valid CAS Registry Number.
953039-79-7Relevant academic research and scientific papers
QUINAZOLINES FOR PDK1 INHIBITION
-
, (2008/06/13)
The invention provides novel quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS
-
Page/Page column 20; 47; 54, (2008/06/13)
The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein: R1, R2, Z1, t, and ring A are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of JNK, such as diabetes, the method comprising administering to a mammal an effective amount of a compound of formula (I).
